G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,590 | -67.9% | 10,132 | -44.5% | 0.00% | – |
Q2 2023 | $45,439 | -99.1% | 18,248 | -99.1% | 0.00% | – |
Q1 2023 | $5,170,214 | +241.8% | 1,929,184 | +592.5% | 0.00% | – |
Q4 2022 | $1,512,619 | -75.8% | 278,567 | -44.3% | 0.00% | -100.0% |
Q3 2022 | $6,242,000 | +158.6% | 499,728 | +2.3% | 0.00% | – |
Q2 2022 | $2,414,000 | -34.9% | 488,707 | +0.2% | 0.00% | – |
Q1 2022 | $3,707,000 | +229.5% | 487,725 | +342.8% | 0.00% | – |
Q4 2021 | $1,125,000 | -89.5% | 110,139 | -86.2% | 0.00% | -100.0% |
Q3 2021 | $10,713,000 | -40.0% | 798,300 | -1.9% | 0.00% | 0.0% |
Q2 2021 | $17,851,000 | -8.8% | 813,641 | +0.0% | 0.00% | -50.0% |
Q1 2021 | $19,575,000 | +17.8% | 813,600 | -11.9% | 0.00% | +100.0% |
Q4 2020 | $16,622,000 | -66.5% | 923,939 | -78.5% | 0.00% | -80.0% |
Q3 2020 | $49,546,000 | -63.9% | 4,289,691 | -24.2% | 0.01% | -66.7% |
Q2 2020 | $137,326,000 | +120.7% | 5,660,589 | +0.3% | 0.02% | +66.7% |
Q1 2020 | $62,223,000 | -58.2% | 5,646,329 | +0.2% | 0.01% | -43.8% |
Q4 2019 | $148,992,000 | +16.2% | 5,637,226 | +0.2% | 0.02% | +6.7% |
Q3 2019 | $128,215,000 | -25.6% | 5,628,388 | +0.1% | 0.02% | -25.0% |
Q2 2019 | $172,311,000 | +85.0% | 5,620,072 | +0.2% | 0.02% | +81.8% |
Q1 2019 | $93,147,000 | -12.8% | 5,611,235 | +0.6% | 0.01% | -26.7% |
Q4 2018 | $106,814,000 | -60.8% | 5,577,754 | +6.9% | 0.02% | -51.6% |
Q3 2018 | $272,780,000 | +28.0% | 5,216,663 | +6.4% | 0.03% | +24.0% |
Q2 2018 | $213,073,000 | +18.7% | 4,902,732 | +1.2% | 0.02% | +19.0% |
Q1 2018 | $179,529,000 | +120.3% | 4,845,576 | +18.0% | 0.02% | +110.0% |
Q4 2017 | $81,476,000 | +29.8% | 4,106,644 | +62.8% | 0.01% | +25.0% |
Q3 2017 | $62,773,000 | +84.1% | 2,522,033 | +29.0% | 0.01% | +100.0% |
Q2 2017 | $34,093,000 | – | 1,954,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |